OncBioMune Broadens Portfolio, Partners and Product with Vitel Acquisition
November 11, 2016 09:09 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA--(Marketwired - November 11, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the...
OncBioMune Signs Term Sheet to Acquire Vitel Laboratorios, S.A. de C.V.
November 03, 2016 08:00 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA--(Marketwired - November 03, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune"), a clinical stage biopharmaceutical company engaged in the development of novel...
Immunotherapy Expert Dr. Brian Barnett Joins OncBioMune Scientific Advisory Board
October 24, 2016 10:47 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA--(Marketwired - October 24, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the...
OncBioMune Receives Notice of Patent Allowance for Novel Cancer Vaccine ProscaVax(TM) in Mexico
October 19, 2016 10:05 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA--(Marketwired - October 19, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the...
OncBioMune Pharmaceuticals Announces Shareholder Update
October 07, 2016 08:00 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA--(Marketwired - October 07, 2016) - OncBioMune Pharmaceuticals Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the...
OncBioMune CEO Dr. Jonathan Head to Present Abstract on Prostate Cancer Vaccine at Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science Into Survival
September 26, 2016 10:41 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA--(Marketwired - September 26, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the...
Prostate Cancer Free for 10 Years, Stephen Karalekas Thanks OncBioMune for ProscaVax in Testimonial Video
September 21, 2016 08:00 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA--(Marketwired - September 21, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the...
OncBioMune Pharmaceuticals in Discussions to Acquire Vitel Laboratorios, S.A. de C.V.
September 14, 2016 07:00 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA--(Marketwired - September 14, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the...
Latest Data From Phase 1 Trial of ProscaVax for Prostate Cancer Reinforces Safety and Benefit of Novel Cancer Vaccine
August 08, 2016 07:00 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA--(Marketwired - August 08, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the...
Pre-Clinical Research Supports Additional Studies of OncBioMune Technology for Breast Cancer Vaccine
July 20, 2016 07:00 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA--(Marketwired - July 20, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development...